January 24, 2024

(LEAD) Samsung Biologics Q4 net falls 21 pct on one-off factor

SEOUL, Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Wednesday its net profit fell 21.4 percent on-year in the fourth quarter of last year due largely to a one-off factor.

Its net income came to 290.7 billion won (US$21…